ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
J&J opens €72M vaccine plant for stepped-up R&D
fiercepharma
December 04, 2018Johnson & Johnson has big ambitions in vaccines, and to get there, its manufacturing has to measure up. The?small plant acquired in its Crucell purchase just won't support its advancing pipeline candidates—and certainly not product launches down the road.
Pharma Sources Insight July 2025
